AOBI OTC
American Oriental Bioengineering, Inc.
1W: +0.0%
1M: +0.0%
3M: +983.3%
YTD: +983.3%
1Y: +1081.8%
3Y: +6400.0%
5Y: -99.5%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$46M
-255.1% ▼
Capital Expenditures
$26M
+47.6% ▲
5Y CAGR: +45.7%
Free Cash Flow
-$73M
-264.5% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$1M
-58.8% ▼
Net Change in Cash
-$46M
-8.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $48M | $41M | $16M | -$68M | -$60M |
| Depreciation & Amort. | $11M | $12M | $13M | $12M | $12M |
| Stock-Based Comp. | $0 | $3M | $3M | $3M | $3M |
| Change in Working Capital | $610K | -$29M | -$25M | $12M | -$7M |
| Other Non-Cash Items | $13M | -$802K | $776K | $76M | $5M |
| Operating Cash Flow | $78M | $25M | $8M | $30M | -$46M |
| — Investing Activities — | |||||
| Capital Expenditures | -$173M | -$5M | -$6M | -$50M | -$26M |
| Acquisitions (Net) | -$53M | $1M | $0 | $6M | $18M |
| Investment Purchases | -$22M | -$239K | -$54K | -$28M | -$5M |
| Investment Sales | $8K | $6M | $0 | $13M | -$7M |
| Other Investing | -$9M | -$1M | -$27K | -$13M | $35M |
| Investing Cash Flow | -$257M | $1M | -$6M | -$72M | $15M |
| — Financing Activities — | |||||
| Net Debt Issuance | $111M | -$3M | -$7M | -$4M | -$8M |
| Stock Repurchased | $0 | $0 | $0 | -$800K | -$1M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$30M | $0 | $3M | $273K | -$6M |
| Financing Cash Flow | $81M | -$3M | -$4M | -$4M | -$15M |
| Net Change in Cash | -$96M | $24M | $3M | -$42M | -$46M |
| Cash End of Period | $71M | $94M | $95M | $53M | $7M |
| Free Cash Flow | -$95M | $20M | $2M | -$20M | -$73M |